Relay Therapeutics IncNASDAQ:RLAY
- LAST PRICE7.3100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots7.0900/ 5
- Ask / Lots9.4700/ 3
- Open / Previous Close0.0000 / 7.3100
- Day Range---
- 52 Week Range
- Volume2
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RLAY |
|---|---|---|
| 09:32 ET | 22545 | 7.54 |
| 09:34 ET | 2820 | 7.65 |
| 09:36 ET | 1596 | 7.6864 |
| 09:38 ET | 200 | 7.6 |
| 09:39 ET | 1602 | 7.52 |
| 09:41 ET | 550 | 7.53 |
| 09:43 ET | 849 | 7.5 |
| 09:45 ET | 27113 | 7.51 |
| 09:48 ET | 5422 | 7.39 |
| 09:50 ET | 1525 | 7.38 |
| 09:52 ET | 2338 | 7.31 |
| 09:54 ET | 2011 | 7.3 |
| 09:56 ET | 1294 | 7.3 |
| 09:57 ET | 3415 | 7.26 |
| 09:59 ET | 4233 | 7.33 |
| 10:01 ET | 1411 | 7.38 |
| 10:03 ET | 1577 | 7.32 |
| 10:06 ET | 400 | 7.28 |
| 10:08 ET | 4814 | 7.25 |
| 10:10 ET | 2694 | 7.2155 |
| 10:12 ET | 5672 | 7.21 |
| 10:14 ET | 65898 | 7.12 |
| 10:15 ET | 735 | 7.17 |
| 10:17 ET | 3582 | 7.2 |
| 10:19 ET | 3410 | 7.16 |
| 10:21 ET | 2615 | 7.19 |
| 10:24 ET | 5681 | 7.23 |
| 10:26 ET | 200 | 7.23 |
| 10:28 ET | 738 | 7.24 |
| 10:30 ET | 585 | 7.21 |
| 10:32 ET | 2063 | 7.18 |
| 10:33 ET | 3683 | 7.185 |
| 10:35 ET | 200 | 7.16 |
| 10:37 ET | 23123 | 7.16 |
| 10:39 ET | 5975 | 7.17 |
| 10:42 ET | 7712 | 7.2 |
| 10:44 ET | 569 | 7.19 |
| 10:46 ET | 2110 | 7.21 |
| 10:48 ET | 5902 | 7.22 |
| 10:50 ET | 2002 | 7.21 |
| 10:51 ET | 100 | 7.2 |
| 10:53 ET | 2204 | 7.18 |
| 10:55 ET | 1526 | 7.18 |
| 10:57 ET | 3395 | 7.21 |
| 11:00 ET | 705 | 7.21 |
| 11:02 ET | 2360 | 7.22 |
| 11:04 ET | 200 | 7.23 |
| 11:06 ET | 700 | 7.225 |
| 11:08 ET | 1644 | 7.2 |
| 11:09 ET | 913 | 7.17 |
| 11:11 ET | 100 | 7.17 |
| 11:13 ET | 142625 | 7.18 |
| 11:15 ET | 2200 | 7.21 |
| 11:18 ET | 4474 | 7.19 |
| 11:20 ET | 22195 | 7.145 |
| 11:22 ET | 2145 | 7.1347 |
| 11:24 ET | 8144 | 7.18 |
| 11:26 ET | 4588 | 7.235 |
| 11:27 ET | 3096 | 7.255 |
| 11:29 ET | 4490 | 7.26 |
| 11:31 ET | 3898 | 7.285 |
| 11:33 ET | 6003 | 7.305 |
| 11:36 ET | 5710 | 7.36 |
| 11:40 ET | 2006 | 7.305 |
| 11:42 ET | 1000 | 7.22 |
| 11:44 ET | 865 | 7.22 |
| 11:45 ET | 1588 | 7.15 |
| 11:47 ET | 1985 | 7.16 |
| 11:49 ET | 600 | 7.16 |
| 11:51 ET | 4863 | 7.17 |
| 11:54 ET | 620 | 7.17 |
| 11:56 ET | 5224 | 7.185 |
| 11:58 ET | 726 | 7.185 |
| 12:00 ET | 506 | 7.17 |
| 12:02 ET | 2073 | 7.18 |
| 12:03 ET | 989 | 7.18 |
| 12:05 ET | 726 | 7.19 |
| 12:07 ET | 3373 | 7.17 |
| 12:09 ET | 1517 | 7.19 |
| 12:12 ET | 800 | 7.2 |
| 12:14 ET | 1703 | 7.18 |
| 12:16 ET | 2086 | 7.19 |
| 12:18 ET | 464 | 7.19 |
| 12:20 ET | 10773 | 7.25 |
| 12:21 ET | 400 | 7.27 |
| 12:23 ET | 4744 | 7.25 |
| 12:27 ET | 600 | 7.25 |
| 12:30 ET | 2545 | 7.25 |
| 12:32 ET | 24309 | 7.23 |
| 12:34 ET | 1575 | 7.22 |
| 12:36 ET | 11913 | 7.255 |
| 12:38 ET | 200 | 7.255 |
| 12:39 ET | 1200 | 7.265 |
| 12:41 ET | 673 | 7.255 |
| 12:43 ET | 3203 | 7.2502 |
| 12:45 ET | 3980 | 7.25 |
| 12:48 ET | 11731 | 7.24 |
| 12:50 ET | 3103 | 7.2501 |
| 12:52 ET | 3300 | 7.27 |
| 12:54 ET | 600 | 7.27 |
| 12:56 ET | 4291 | 7.22 |
| 12:57 ET | 4928 | 7.26 |
| 12:59 ET | 511 | 7.28 |
| 01:03 ET | 498 | 7.29 |
| 01:06 ET | 600 | 7.28 |
| 01:08 ET | 2709 | 7.31 |
| 01:10 ET | 4530 | 7.3 |
| 01:12 ET | 500 | 7.31 |
| 01:14 ET | 11839 | 7.315 |
| 01:15 ET | 4497 | 7.315 |
| 01:17 ET | 9080 | 7.34 |
| 01:19 ET | 2230 | 7.35 |
| 01:21 ET | 500 | 7.35 |
| 01:24 ET | 800 | 7.34 |
| 01:26 ET | 3695 | 7.32 |
| 01:28 ET | 4549 | 7.36 |
| 01:30 ET | 600 | 7.36 |
| 01:32 ET | 1400 | 7.35 |
| 01:33 ET | 500 | 7.35 |
| 01:35 ET | 3970 | 7.34 |
| 01:37 ET | 1332 | 7.34 |
| 01:39 ET | 1880 | 7.31 |
| 01:42 ET | 700 | 7.305 |
| 01:44 ET | 64020 | 7.3387 |
| 01:46 ET | 18859 | 7.365 |
| 01:48 ET | 1100 | 7.38 |
| 01:50 ET | 64447 | 7.415 |
| 01:51 ET | 7375 | 7.41 |
| 01:53 ET | 810 | 7.39 |
| 01:55 ET | 1491 | 7.33 |
| 01:57 ET | 300 | 7.32 |
| 02:00 ET | 300 | 7.29 |
| 02:02 ET | 1325 | 7.28 |
| 02:04 ET | 2456 | 7.29 |
| 02:06 ET | 900 | 7.3 |
| 02:08 ET | 2417 | 7.3 |
| 02:09 ET | 402 | 7.27 |
| 02:11 ET | 600 | 7.28 |
| 02:13 ET | 400 | 7.28 |
| 02:15 ET | 4721 | 7.28 |
| 02:18 ET | 2932 | 7.32 |
| 02:20 ET | 2342 | 7.31 |
| 02:22 ET | 3532 | 7.325 |
| 02:24 ET | 400 | 7.32 |
| 02:26 ET | 100 | 7.32 |
| 02:27 ET | 1964 | 7.315 |
| 02:29 ET | 270 | 7.31 |
| 02:31 ET | 4218 | 7.305 |
| 02:33 ET | 1869 | 7.315 |
| 02:36 ET | 403 | 7.29 |
| 02:38 ET | 532 | 7.28 |
| 02:40 ET | 100 | 7.28 |
| 02:42 ET | 2285 | 7.275 |
| 02:44 ET | 2338 | 7.27 |
| 02:45 ET | 400 | 7.27 |
| 02:47 ET | 200 | 7.27 |
| 02:49 ET | 3741 | 7.3 |
| 02:51 ET | 1699 | 7.32 |
| 02:54 ET | 2726 | 7.315 |
| 02:56 ET | 775 | 7.33 |
| 02:58 ET | 1400 | 7.3575 |
| 03:00 ET | 1860 | 7.355 |
| 03:02 ET | 4372 | 7.34 |
| 03:03 ET | 2871 | 7.365 |
| 03:05 ET | 400 | 7.3675 |
| 03:07 ET | 1501 | 7.3575 |
| 03:09 ET | 10686 | 7.38 |
| 03:12 ET | 5419 | 7.365 |
| 03:14 ET | 2796 | 7.3575 |
| 03:16 ET | 2000 | 7.36 |
| 03:18 ET | 4609 | 7.33 |
| 03:20 ET | 3406 | 7.3324 |
| 03:21 ET | 1712 | 7.33 |
| 03:23 ET | 8044 | 7.35 |
| 03:25 ET | 2137 | 7.335 |
| 03:27 ET | 1188 | 7.33 |
| 03:30 ET | 2860 | 7.365 |
| 03:32 ET | 5705 | 7.37 |
| 03:34 ET | 2449 | 7.37 |
| 03:36 ET | 800 | 7.37 |
| 03:38 ET | 8126 | 7.365 |
| 03:39 ET | 6873 | 7.341 |
| 03:41 ET | 3526 | 7.345 |
| 03:43 ET | 7109 | 7.31 |
| 03:45 ET | 4562 | 7.33 |
| 03:48 ET | 5270 | 7.3 |
| 03:50 ET | 4173 | 7.32 |
| 03:52 ET | 13084 | 7.315 |
| 03:54 ET | 12361 | 7.28 |
| 03:56 ET | 26240 | 7.2675 |
| 03:57 ET | 68974 | 7.265 |
| 03:59 ET | 70072 | 7.31 |
Jun 7, 2024
DJ Relay Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co., from 7:08AM ET on Friday Jun 07, 2024 by Dow Jones
7:08AM ET on Friday Jun 07, 2024 by Dow Jones
Jun 6, 2024
Relay Therapeutics Discloses Three New Programs at New Program & Platform Event, from 7:00AM ET on Thursday Jun 06, 2024 by Dow Jones
7:00AM ET on Thursday Jun 06, 2024 by Dow Jones
Jun 5, 2024
DJ Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment, from 5:38PM ET on Wednesday Jun 05, 2024 by Dow Jones
5:38PM ET on Wednesday Jun 05, 2024 by Dow JonesRelay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608, from 4:05PM ET on Wednesday Jun 05, 2024 by Dow Jones
4:05PM ET on Wednesday Jun 05, 2024 by Dow Jones
May 21, 2024
Relay Therapeutics to Participate in Upcoming Investor Conferences, from 4:05PM ET on Tuesday May 21, 2024 by Dow Jones
4:05PM ET on Tuesday May 21, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Relay Therapeutics Inc | 970.3M | -2.8x | --- |
Tango Therapeutics Inc | 954.1M | -8.1x | --- |
Abcellera Biologics Inc | 949.8M | -6.4x | --- |
Immunome Inc | 894.7M | -2.7x | --- |
Cassava Sciences Inc | 946.1M | -16.9x | --- |
Enliven Therapeutics Inc | 1.0B | -11.3x | --- |
Company Information
Relay Therapeutics Inc. is a clinical-stage precision medicine company. The Company is focused on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The Company’s Dynamo platform integrates an array of computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. The Company’s lead product candidates, such as RLY-2608, Lirafugratinib (RLY-4008), and Migoprotafib (GDC-1971). RLY-2608 is an allosteric, pan-mutant and isoform-selective phosphoinostide 3 kinase alphas (PI3Kα), inhibitor. RLY-4008, is a potent, selective, and oral small molecule inhibitor of FGFR2, a receptor tyrosine kinase that is frequently altered in certain cancers. GDC-1971 is an inhibitor of Src homology region 2 domain-containing phosphatase-2 (SHP2), as a monotherapy in patients with advanced or metastatic solid tumors.
Contact Information
- Headquarters
- 399 Binney Street, 2Nd FloorCAMBRIDGE, MA, United States 02139
- Phone
- 617-370-8837
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Alexis Borisy
- President, Chief Executive Officer, Director
- Sanjiv Patel
- Chief Financial Officer
- Thomas Catinazzo
- President - Research and Development
- Donald Bergstrom
- Chief Corporate Development Officer
- Peter Rahmer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $970.3M |
|---|---|
Revenue (TTM) | $35.3M |
Shares Outstanding | 132.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.68 |
EPS | $-2.64 |
Book Value | $5.90 |
P/E Ratio | -2.8x |
Price/Sales (TTM) | 27.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,025.24% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
